Skip to content
HowShorted

Alaunos Therapeutics, Inc. short interest in 2026

In 2026, Alaunos Therapeutics, Inc.'s disclosed short interest ran from 2.34% of shares outstanding on 15 Jan 2026 to 0.24% on 15 Sep 2026, a change of -2.10 percentage points. The year's high was 2.34% on 15 Jan 2026 and its low 0.22% on 31 Aug 2026, averaging 0.81% across 16 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.23 days on 13 Feb 2026. Full history: Alaunos Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Alaunos Therapeutics, Inc. in 2026

2026 in figures

Start of year
2.34% (15 Jan 2026)
End of year
0.24% (15 Sep 2026)
Change
-2.10 pp
High
2.34% (15 Jan 2026)
Low
0.22% (31 Aug 2026)
Average
0.81%
Highest days to cover
3.23 (13 Feb 2026)
SEC filings marked
3

Every report in 2026

Alaunos Therapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 20262.34%1.25
30 Jan 20262.00%2.83
13 Feb 20261.71%3.23
27 Feb 20261.53%2.92
31 Mar 20260.60%1.0010-K filed
15 Apr 20260.52%1.00
30 Apr 20260.37%1.00
15 May 20260.33%1.0010-Q filed
29 May 20260.58%1.00
15 Jun 20260.49%1.00
30 Jun 20260.62%1.05
15 Jul 20260.56%1.00
31 Jul 20260.41%1.00
14 Aug 20260.49%1.5510-Q filed
31 Aug 20260.22%1.00
15 Sep 20260.24%1.00

See also: Alaunos Therapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.